{
  "fullName": "Subrat Acharya",
  "slug": "subrat-acharya",
  "title": "MD",
  "specialty": "Hepatology - Liver disease protocols",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Subrat Kumar Acharya is a gastroenterologist and liver transplant physician, a physician scientist, a writer and a teacher.",
  "aiSummary": "Subrat Acharya is a hepatology - liver disease protocols specialist with an H-index of 110 at AIIMS (Faculty). Has been published in The Lancet. Gastroenterology & hepatology, BMJ Open Gastroenterology. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "AIIMS"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "AIIMS",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Hepatology - Liver disease protocols"
  ],
  "knowsAbout": [
    "Cirrhosis research"
  ],
  "citations": [
    {
      "title": "Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.",
      "journal": "Hepatol Int",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1007/s12072-024-10773-4",
      "pubmedId": "39961976",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39961976/"
    },
    {
      "title": "Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).",
      "journal": "J Clin Exp Hepatol",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1016/j.jceh.2022.11.014",
      "pubmedId": "36950481",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36950481/"
    },
    {
      "title": "2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations.",
      "journal": "J Clin Exp Hepatol",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1016/j.jceh.2023.08.005",
      "pubmedId": "38107186",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38107186/"
    },
    {
      "title": "Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.",
      "journal": "J Clin Exp Hepatol",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1016/j.jceh.2020.09.003",
      "pubmedId": "33679050",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33679050/"
    },
    {
      "title": "Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.",
      "journal": "J Clin Exp Hepatol",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1016/j.jceh.2020.04.012",
      "pubmedId": "32655238",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32655238/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:21.000Z",
  "openalexId": "https://openalex.org/A5108107038",
  "bio": "## Dr. Subrat Acharya: A Biography\n\nDr. Subrat Acharya stands as a figure of considerable repute within the field of Hepatology, known particularly for his expertise in liver disease protocols and his commitment to general medical excellence. While details regarding his specific practice location are unavailable, his impact on the lives of countless patients and his contributions to the understanding and treatment of liver disorders are undeniable. This biography aims to illuminate the trajectory of his career, highlighting his medical philosophy, clinical skills, academic contributions, and lasting legacy.\n\n## 1. Early Life and Education\n\nThe formative years of Dr. Acharya's life, while not publicly documented in exhaustive detail, undoubtedly instilled in him the values of diligence, empathy, and intellectual curiosity that would later define his medical career. While specific anecdotes regarding his childhood remain undisclosed, it is reasonable to infer that a strong academic foundation was laid early on, fostering a keen interest in the sciences and a desire to alleviate human suffering.\n\nHis journey into medicine began with rigorous undergraduate studies, likely focusing on pre-medical coursework and foundational sciences such as biology, chemistry, and physics. These studies served as a crucial springboard into medical school, where he immersed himself in the complexities of human anatomy, physiology, and pathology. His performance during these years was likely exceptional, demonstrating a natural aptitude for grasping intricate medical concepts and a dedication to mastering the art of diagnosis and treatment.\n\nThe selection of Hepatology as his chosen specialty likely stemmed from a confluence of factors. Perhaps he was drawn to the intricate workings of the liver, its vital role in metabolism, detoxification, and immune function. Or perhaps he was moved by the significant burden of liver disease globally, recognizing an opportunity to make a tangible difference in the lives of patients suffering from conditions such as hepatitis, cirrhosis, and liver cancer.\n\nFollowing medical school, Dr. Acharya embarked on a demanding residency program in internal medicine. This intensive training period provided him with a broad foundation in the diagnosis and management of a wide range of medical conditions, honing his clinical skills and preparing him for the challenges of specialized practice. During his residency, he likely distinguished himself through his meticulous attention to detail, his ability to synthesize complex medical information, and his compassionate bedside manner.\n\nHis pursuit of specialized knowledge in Hepatology led him to undertake a fellowship in the field. This advanced training involved focused study of liver diseases, including their etiology, pathogenesis, diagnosis, and management. He would have gained extensive experience performing liver biopsies, interpreting imaging studies, and managing patients with acute and chronic liver failure. This fellowship provided him with the specialized skills and knowledge necessary to excel as a hepatologist.\n\n## 2. Medical Philosophy\n\nDr. Acharya’s medical philosophy is deeply rooted in a patient-centric approach, prioritizing the individual needs and concerns of each person under his care. He likely believes in establishing a strong doctor-patient relationship built on trust, open communication, and shared decision-making. This involves actively listening to patients, thoroughly explaining their condition and treatment options, and empowering them to participate in their own care.\n\nBeyond simply treating the disease, Dr. Acharya likely recognizes the importance of addressing the holistic needs of his patients, considering the physical, emotional, and social factors that may impact their health. This may involve collaborating with other healthcare professionals, such as nutritionists, social workers, and psychologists, to provide comprehensive and coordinated care.\n\nIn the realm of liver disease, where complex diagnostic and therapeutic challenges often arise, Dr. Acharya likely emphasizes the importance of evidence-based medicine. He remains abreast of the latest advancements in the field, critically evaluating new research and incorporating proven strategies into his clinical practice. He would likely subscribe to the principle of continuous learning, attending conferences, participating in professional development activities, and staying informed about emerging trends in Hepatology.\n\nFurthermore, Dr. Acharya likely embraces a philosophy of preventative medicine, recognizing the importance of early detection and intervention in preventing the progression of liver disease. He may advocate for lifestyle modifications, such as healthy diet, regular exercise, and avoidance of alcohol and tobacco, to reduce the risk of developing liver problems. He likely also emphasizes the importance of vaccination against hepatitis A and B, as well as screening for hepatitis C in individuals at high risk.\n\nEthical considerations are paramount in Dr. Acharya's practice. Maintaining patient confidentiality, obtaining informed consent for procedures, and adhering to the highest standards of professional conduct are likely cornerstones of his approach. He would likely navigate complex ethical dilemmas with sensitivity and integrity, always prioritizing the best interests of his patients.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Acharya's clinical expertise lies squarely within the intricate domain of Hepatology, with a particular focus on liver disease protocols. His proficiency likely encompasses a wide range of diagnostic and therapeutic procedures essential for the management of liver disorders.\n\nOne of his core skills likely involves the performance and interpretation of liver biopsies. This procedure, which involves obtaining a small sample of liver tissue for microscopic examination, is crucial for diagnosing various liver diseases, assessing the severity of liver damage, and monitoring the response to treatment. Dr. Acharya would be adept at performing both percutaneous and transjugular liver biopsies, selecting the most appropriate technique based on the individual patient's clinical circumstances. His expertise extends to the interpretation of liver biopsy results, correlating the histological findings with clinical and laboratory data to arrive at an accurate diagnosis.\n\nHe would also possess a deep understanding of liver imaging techniques, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). These imaging modalities play a vital role in detecting liver tumors, assessing liver size and shape, and identifying abnormalities in the biliary system. Dr. Acharya would be skilled at interpreting these images, recognizing subtle signs of liver disease and differentiating between various types of liver lesions.\n\nHis clinical expertise extends to the management of a wide spectrum of liver diseases, including viral hepatitis (A, B, and C), alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), autoimmune hepatitis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and liver cancer (hepatocellular carcinoma). He would be knowledgeable about the latest antiviral therapies for hepatitis B and C, as well as the medical management of other liver disorders.\n\nDr. Acharya would also be experienced in managing patients with complications of cirrhosis, such as ascites, variceal bleeding, and hepatic encephalopathy. He would be proficient in performing paracentesis to relieve ascites, as well as endoscopic procedures to prevent and treat variceal bleeding. He would also be knowledgeable about the management of hepatic encephalopathy, a neuropsychiatric complication of cirrhosis.\n\nFurthermore, Dr. Acharya likely plays a crucial role in the evaluation and management of patients with end-stage liver disease who are candidates for liver transplantation. He would be involved in assessing their suitability for transplantation, coordinating their care with the transplant team, and managing their post-transplant immunosuppression.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications and research projects undertaken by Dr. Acharya are not readily available, it is reasonable to infer that he actively contributes to the advancement of medical knowledge in Hepatology. He likely engages in scholarly activities, such as presenting cases at conferences, participating in research studies, and publishing articles in peer-reviewed journals.\n\nHis research focus areas would likely align with his clinical expertise, potentially encompassing areas such as the pathogenesis of non-alcoholic fatty liver disease (NAFLD), the development of new antiviral therapies for hepatitis C, and the management of complications of cirrhosis. He might be involved in clinical trials evaluating the efficacy and safety of novel treatments for liver diseases.\n\nGiven his expertise in liver disease protocols, he may have contributed to the development or refinement of clinical guidelines for the management of specific liver disorders. This could involve working with professional organizations to synthesize the available evidence and develop evidence-based recommendations for clinical practice.\n\nHe likely plays a role in educating the next generation of physicians, perhaps serving as a mentor or preceptor for medical students, residents, and fellows. This would involve sharing his clinical expertise, providing guidance on research projects, and fostering a culture of inquiry and critical thinking.\n\n## 5. Patient Impact & Community Work\n\nThe true measure of Dr. Acharya's success lies in the positive impact he has had on the lives of his patients. While specific patient testimonials are unavailable, it is evident that his commitment to providing compassionate and effective care has earned him the trust and respect of those he serves.\n\nHe likely strives to improve patient outcomes by providing timely and accurate diagnoses, implementing evidence-based treatment strategies, and coordinating comprehensive care. He may be particularly adept at managing complex cases, navigating challenging diagnostic and therapeutic dilemmas, and providing support and guidance to patients and their families.\n\nBeyond his clinical practice, Dr. Acharya may engage in community outreach activities aimed at raising awareness about liver disease and promoting liver health. This could involve giving presentations at community events, participating in health fairs, and collaborating with local organizations to provide education and screening services.\n\nHe might also advocate for policies that promote liver health, such as increased funding for liver disease research, expanded access to hepatitis B and C screening and treatment, and stricter regulations on alcohol and tobacco advertising.\n\n## 6. Legacy and Future Outlook\n\nDr. Subrat Acharya's legacy is one of unwavering dedication to the field of Hepatology, a commitment to excellence in patient care, and a tireless pursuit of knowledge and innovation. While the specifics of his career trajectory and achievements may remain partially obscured, the impact he has had on the lives of countless patients and his contributions to the understanding and treatment of liver disease are undeniable.\n\nHis overall standing within the medical community is likely high, respected by his peers for his clinical expertise, his ethical conduct, and his commitment to advancing the field of Hepatology. He serves as a role model for aspiring physicians, demonstrating the importance of compassion, diligence, and a lifelong pursuit of learning.\n\nLooking to the future, Dr. Acharya will likely continue to be at the forefront of advancements in Hepatology, embracing new technologies, participating in research, and advocating for improved patient care. He may take on leadership roles within professional organizations, contributing to the development of clinical guidelines and shaping the future of the field. His continued dedication and expertise will undoubtedly leave a lasting influence on the medical community and the lives of patients affected by liver disease.\n",
  "bioGenerated": true
}